Co-Diagnostics, Inc. ( CODX) - Key Metrics
CODX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.04 | -$1.46 | -$1.66 | -$1.66 |
| 2026Q1 | $0.06 | -$4.06 | -$3.48 | -$3.54 |
| 2025Q4 | $0.20 | -$19.35 | -$4.66 | -$4.76 |
| 2025Q3 | $0.12 | -$4.66 | -$4.67 | -$4.73 |
| 2025Q2 | $0.15 | -$7 | -$7.51 | -$7.87 |
CODX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.53 |
| 2026Q1 | 0% | -0.11 |
| 2025Q4 | 0% | -0.08 |
| 2025Q3 | 0% | -0.55 |
| 2025Q2 | 0% | -0.30 |
CODX
Price: $1.26
52 week price:
Earnings Per Share: -25.89 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 111400
Market Capitalization: 4.9 million